Skin involvement in cutaneous and systemic vasculitis

Autoimmunity Reviews

Volumn 12, Issue 4, 2013, Pages 467-476

  Marzano, Angelo V ^a   Vezzoli, Pamela ^a   Berti, Emilio ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Connective tissue diseases; Cutaneous vasculitis; Livedoid vasculopathy; Systemic vasculitis

Indexed keywords

ANAPHYLACTOID PURPURA; ANKLE; ANOREXIA; ANTIGEN ANTIBODY COMPLEX; ARM; ARTHRALGIA; AUTOIMMUNE DISEASE; CELL DESTRUCTION; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; COMPLEMENT SYSTEM; CONNECTIVE TISSUE; CONNECTIVE TISSUE DISEASE; CUTANEOUS SMALL VESSEL VASCULITIS; DEGRANULATION; HUMAN; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTOCLASTIC VASCULITIS; LIVEDO RETICULARIS; LIVEDOID VASCULOPATHY; MYALGIA; POLYARTERITIS NODOSA; REVIEW; SKIN BLOOD VESSEL; SKIN DEFECT; SMALL VESSEL VASCULITIS; SYSTEMIC VASCULITIS; TRUNK; UPPER RESPIRATORY TRACT INFECTION; URTICARIAL VASCULITIS; VASCULITIS; WEGENER GRANULOMATOSIS; PATHOLOGY; SKIN;

HUMANS; SKIN; SYSTEMIC VASCULITIS;

MLCS; MLOWN;

EID: 84878566716     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2012.08.005     Document Type: Review

References (116)

1. Decleva I., Marzano A.V., Barbareschi M., Berti E. Cutaneous manifestations in systemic vasculitis. Clin Rev Allergy Immunol 1997, 15:5-20.
2. Jennette J.C., Falk R.J., Andrassy K., Bacon P.A., Churg J., Gross W.L., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994, 37:187-192.
3. Cox N.H., Jorizzo J.L., Bourke J.F., Savage C.O.S. Vasculitis neutrophilic dermatoses and related disorders. Rook's textbook of dermatology 2010, Wiley-Blackwell, Oxford. T. Burns, S. Breathnach, N. Cox, C. Griffiths (Eds.).
4. Villiger P.M., Guillevin L. Microscopic polyangiitis: clinical presentation. Autoimmun Rev Oct 2010, 9(12):812-819.
5. Sinico R.A., Di Toma L., Radice A. Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis. Autoimmun Rev 2013, 12(4):477-482. (this issue).
6. Marzano A.V., Vanotti M., Alessi E. Widespread livedoid vasculopathy. Acta Derm Venereol 2003, 83:457-460.
7. Khenifer S., Thomas L., Balme B., Dalle S. Livedoid vasculitis associated with a double heterozygous factor V Leiden and prothrombin G20210A gene mutations. Clin Exp Dermatol 2009, 34:811-813.
8. Jennette J.C., Falk R.J. Small-vessel vasculitis. N Engl J Med 1998, 337:1512-1523.
9. Carlson J.A., Chen K.R. Cutaneous vasculitis update: small vessel neutrophilic vasculitis syndromes. Am J Dermatopathol 2006, 28:486-506.
10. Chen K.R., Carlson J.A. Clinical approach to cutaneous vasculitis. Am J Clin Dermatol 2008, 9:71-92.
11. Fiorentino D.F. Cutaneous vasculitis. J Am Acad Dermatol 2003, 48:311-340.
12. ten Holder S.M., Joy M.S., Falk R.J. Cutaneous and systemic manifestations of drug-induced vasculitis. Ann Pharmacother 2002, 36:130-147.
13. Arnaud L., Haroche J., Mathian A., Gorochov G., Amoura Z. Pathogenesis of Takayasu's arteritis: a 2011 update. Autoimmun Rev Nov 2011, 11(1):61-67.
14. Alexoudi I., Kanakis M., Kapsimali V., Vaiopoulos G. Kawasaki disease: current aspects on aetiopathogenesis and therapeutic management. Autoimmun Rev Jul 2011, 10(9):544-547.
15. Mendoza-Pinto C., García-Carrasco M., Jiménez-Hernández M., Jiménez Hernández C., Riebeling-Navarro C., Nava Zavala A., et al. Etiopathogenesis of Behcet's disease. Autoimmun Rev Feb 2010, 9(4):241-245.
16. Kallenberg C.G., Tadema H. Vasculitis and infections: contribution to the issue of autoimmunity reviews devoted to "autoimmunity and infection". Autoimmun Rev Oct 2008, 8(1):29-32.
17. Pietrogrande M., De Vita S., Zignego A.L., Pioltelli P., Sansonno D., Sollima S., et al. Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients. Autoimmun Rev Jun 2011, 10(8):444-454.
18. Lotti T., Ghersetich I., Comacchi C., Jorizzo J.L. Cutaneous small-vessel vasculitis. J Am Acad Dermatol 1998, 39:667-687. [quiz 688-90].
19. Sinico R.A., Meroni P.L. The kaleidoscopic manifestations of systemic vasculitis. Autoimmun Rev 2013, 12(4):459-462. (this issue).
20. Hu N., Westra J., Kallenberg C.G. Dysregulated neutrophil-endothelial interaction in antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides: implications for pathogenesis and disease intervention. Autoimmun Rev Jul 2011, 10(9):536-543.
21. Chen M., Kallenberg C.G. The environment, geoepidemiology and ANCA-associated vasculitides. Autoimmun Rev Mar 2010, 9(5):A293-A298.
22. Witort-Serraglini E., Del Rosso M., Lotti T.M., Matucci-Cerinic M. Endothelial injury in vasculitides. Clin Dermatol 1999, 17:587-590.
23. Kluger M.S. Vascular endothelial cell adhesion and signaling during leukocyte recruitment. Adv Dermatol 2004, 20:163-201.
24. Comacchi C., Ghersetich I., Katsambas A., Lotti T.M. Gamma/delta T lymphocytes and infection: pathogenesis of leukocytoclastic cutaneous necrotizing vasculitis. Clin Dermatol 1999, 17:603-607.
25. Lee J.S., Kossard S., McGrath M.A. Lymphocytic thrombophilic arteritis: a newly described medium-sized vessel arteritis of the skin. Arch Dermatol 2008, 144:1175-1182.
26. Schilder A.M. Wegener's granulomatosis vasculitis and granuloma. Autoimmun Rev 2010, 9(7):483-487.
27. Meroni P.L., Raschi E., Testoni C., Tincani A., Balestrieri G. Antiphospholipid antibodies and the endothelium. Rheum Dis Clin North Am 2001, 27:587-602.
28. Radice A., Bianchi L., Sinico R.A. Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis. Autoimmun Rev 2013, 12(4):487-495. (this issue).
29. Guilpain P., Mouthon L. Antiendothelial cells autoantibodies in vasculitis-associated systemic diseases. Clin Rev Allergy Immunol 2008, 35:59-65.
30. Blanco R., Martínez-Taboada V.M., Rodríguez-Valverde V., García-Fuentes M. Cutaneous vasculitis in children and adults. Associated diseases and etiologic factors in 303 patients. Medicine 1998, 77:403-418.
31. Sais G., Vidaller A., Jucglà A., Servitje O., Condom E., Peyri J. Prognostic factors in leukocytoclastic vasculitis: a clinicopathologic study of 160 patients. Arch Dermatol 1998, 134:309-315.
32. Gonzalez-Gay M.A., Garcia-Porrua C., Pujol R.M. Clinical approach to cutaneous vasculitis. Curr Opin Rheumatol 2005, 17:56-61.
33. Tai Y.J., Chong A.H., Williams R.A., Cumming S., Kelly R.I. Retrospective analysis of adult patients with cutaneous leukocytoclastic vasculitis. Australas J Dermatol 2006, 47:92-96.
34. Crowson A.N., Mihm M.C., Magro C.M. Cutaneous vasculitis: a review. J Cutan Pathol 2003, 30:161-173.
35. Ioannidou D.J., Krasagakis K., Daphnis E.K., Perakis K.E., Sotsiou F., Tosca A.D. Cutaneous small vessel vasculitis: an entity with frequent renal involvement. Arch Dermatol 2002, 138:412-414.
36. Carlson J.A. The histological assessment of cutaneous vasculitis. Histopathology 2010, 56:3-23.
37. Bahrami S., Malone J.C., Webb K.G., Callen J.P. Tissue eosinophilia as an indicator of drug-induced cutaneous small-vessel vasculitis. Arch Dermatol 2006, 142:155-161.
38. Callen J.P., Spencer L.V., Burruss J.B., Holtman J. Azathioprine. An effective, corticosteroid-sparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis. Arch Dermatol 1991, 127:515-522.
39. Boehm I., Bauer R. Low-dose methotrexate controls a severe form of polyarteritis nodosa. Arch Dermatol 2000, 136:167-169.
40. Fredenberg M.F., Malkinson F.D. Sulfone therapy in the treatment of leukocytoclastic vasculitis. Report of three cases. J Am Acad Dermatol 1987, 16:772-778.
41. Vezzoli P. Le vasculiti cutanee: studio degli aspetti clinici e valutazione dell'efficacia terapeutica di ciclosporina per via orale. G Ital Dermatol Venereol 2010, 145:55-58. [Suppl.].
42. Uthman I.W., Touma Z., Sayyad J., Salman S. Response of deep cutaneous vasculitis to infliximab. J Am Acad Dermatol 2005, 53:353-354.
43. Chung L., Funke A.A., Chakravarty E.F., Callen J.P., Fiorentino D.F. Successful use of rituximab for cutaneous vasculitis. Arch Dermatol 2006, 142:1407-1410.
44. Anandacoomarasamy A., Kannangara S., BarnsleyL L. Cutaneous vasculitis associated with infliximab in the treatment of rheumatoid arthritis. Intern Med J Oct 2005, 35(10):638-640.
45. Kandula P., Kouides P.A. Rituximab-induced leukocytoclastic vasculitis: a case report. Arch Dermatol 2006, 142:246-247.
46. Black A.K. Urticarial vasculitis. Clin Dermatol 1999, 17:565-569.
47. Wisnieski J.J. Urticarial vasculitis. Curr Opin Rheumatol 2000, 12:24-31.
48. Venzor J., Lee WL, Huston D.P. Urticarial vasculitis. Clin Rev Allergy Immunol 2002, 23:201-216.
49. Wisnieski J.J., Baer A.N., Christensen J., Cupps T.R., Flagg D.N., Jones J.V., et al. Hypocomplementemic urticarial vasculitis syndrome. Clinical and serologic findings in 18 patients. Medicine 1995, 74:24-41.
50. Grotz W., Baba H.A., Becker J.U., Baumgärtel M.W. Hypocomplementemic urticarial vasculitis syndrome: an interdisciplinary challenge. Dtsch Arztebl Int 2009, 106:756-763.
51. Van der Horst J.C., Bronsveld W. Urticarial vasculitis in a patient with systemic lupus erythematosus: a case report. Clin Exp Dermatol 1981, 6:489-494.
52. O'Loughlin S., Schroeter A.L., Jordon R.E. Chronic urticaria-like lesions in systemic lupus erythematosus. A review of 12 cases. Arch Dermatol 1978, 114:879-883.
53. Berg R.E., Kantor G.R., Bergfeld W.F. Urticarial vasculitis. Int J Dermatol 1988, 27:468-472.
54. Mehregan D.R., Gibson L.E. Pathophysiology of urticarial vasculitis. Arch Dermatol 1998, 134:88-89.
55. Wisnieski J.J., Jones S.M. Comparison of autoantibodies to the collagen-like region of C1q in hypocomplementemic urticarial vasculitis syndrome and systemic lupus erythematosus. J Immunol 1992, 148:1396-1403.
56. Wisnieski J.J., Jones S.M. IgG autoantibody to the collagen-like region of Clq in hypocomplementemic urticarial vasculitis syndrome, systemic lupus erythematosus, and 6 other musculoskeletal or rheumatic diseases. J Rheumatol 1992, 19:884-888.
57. Sanchez N.P., Winkelmann R.K., Schroeter A.L., Dicken C.H. The clinical and histopathologic spectrums of urticarial vasculitis: study of forty cases. J Am Acad Dermatol 1982, 7:599-605.
58. Mehregan D.R., Hall M.J., Gibson L.E. Urticarial vasculitis: a histopathologic and clinical review of 72 cases. J Am Acad Dermatol 1992, 26:441-448.
59. Callen J.P., Kalbfleisch S. Urticarial vasculitis: a report of nine cases and review of the literature. Br J Dermatol 1982, 107:87-93.
60. Davis M.D., Daoud M.S., Kirby B., Gibson L.E., Rogers R.S. Clinicopathologic correlation of hypocomplementemic and normocomplementemic urticarial vasculitis. J Am Acad Dermatol 1998, 38:899-905.
61. Lee J.S., Loh T.H., Seow S.C., Tan S.H. Prolonged urticaria with purpura: the spectrum of clinical and histopathologic features in a prospective series of 22 patients exhibiting the clinical features of urticarial vasculitis. J Am Acad Dermatol 2007, 56:994-1005.
62. Browning C.E., Callen J.P. Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia. Arch Dermatol 2006, 142:75-78.
63. Jorizzo J.L. Livedoid vasculopathy: what is it?. Arch Dermatol 1998, 134:491-493.
64. Acland K.M., Darvay A., Wakelin S.H., Russell-Jones R. Livedoid vasculitis: a manifestation of the antiphospholipid syndrome?. Br J Dermatol 1999, 140:131-135.
65. Papi M., Didona B., De Pità O., Frezzolini A., Di Giulio S., De Matteis W., et al. Livedo vasculopathy vs small vessel cutaneous vasculitis: cytokine and platelet P-selectin studies. Arch Dermatol 1998, 134:447-452.
66. Calamia K.T., Balabanova M., Perniciaro C., WalshS J.S. Livedo (livedoid) vasculitis and the factor V Leiden mutation: additional evidence for abnormal coagulation. J Am Acad Dermatol 2002, 46:133-137.
67. Hegemann B., Helmbold P., Marsch W.C. Livedoid vasculitis with ulcerations: the role of antithrombin III deficiency and its therapeutic consequences. Arch Dermatol 2002, 138:841-842.
68. Boyvat A., Kundakçi N., Babikir M.O., Gürgey E. Livedoid vasculopathy associated with heterozygous protein C deficiency. Br J Dermatol 2000, 143:840-842.
69. Cocuroccia B., Tonanzi T., Menaguale G., Fazio M., Girolomoni G. Livedoid vasculopathy and skin ulcers in patients with inherited thrombophilia. Eur J Dermatol 2002, 12:360-363.
70. Deng A., Gocke C.D., Hess J., Heyman M., Paltiel M., Gaspari A. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator. Arch Dermatol 2006, 142:1466-1469.
71. Meiss F., Marsch W.C., Fischer M. Livedoid vasculopathy. The role of hyperhomocysteinemia and its simple therapeutic consequences. Eur J Dermatol 2006, 16:159-162.
72. Kavala M., Kocaturk E., Zindanci I., Turkoglu Z., Altintas S. A case of livedoid vasculopathy associated with factor V Leiden mutation: successful treatment with oral warfarin. J Dermatolog Treat 2008, 19:121-123.
73. Irani-Hakime N.A., Stephan F., Kreidy R., Jureidini I., Almawi W.Y. Livedoid vasculopathy associated with combined prothrombin G20210A and Factor V (Leiden) heterozygosity and MTHFR C677T homozygosity. J Thromb Thrombolysis 2008, 26:31-34.
74. Yasue T. Livedoid vasculitis and central nervous system involvement in systemic lupus erythematosus. Arch Dermatol 1986, 122:66-70.
75. Hairston B.R., Davis M.D., Pittelkow M.R. Ahmed I. Livedoid vasculopathy: further evidence for procoagulant pathogenesis. Arch Dermatol 2006, 142:1413-1418.
76. Oh Y.B., Jun J.B., Kim C.K., Lee C.W., Park C.K., Kim T.Y., et al. Mixed connective tissue disease associated with skin defects of livedoid vasculitis. Clin Rheumatol 2000, 19:381-384.
77. Mimouni D., Ng P.P., Rencic A., Nikolskaia O.V., Bernstein B.D., Nousari H.C. Cutaneous polyarteritis nodosa in patients presenting with atrophie blanche. Br J Dermatol 2003, 148:789-794.
78. Francès C., Barete S. Difficult management of livedoid vasculopathy. Arch Dermatol 2004, 140:1011.
79. Gertner E. Treatment with sildenafil for the healing of refractory skin ulcerations in the antiphospholipid syndrome. Lupus 2003, 12:133-135.
80. Ozen S., Ruperto N., Dillon M.J., Bagga A., Barron K., Davin J.C., et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 2006, 65:936-941.
81. Saulsbury F.T. Clinical update: Henoch-Schönlein purpura. Lancet 2007, 369:976-978.
82. Yang Y.H., Chuang Y.H., Wang L.C., Huang H.Y., Gershwin M.E., Chiang B.L. The immunobiology of Henoch-Schönlein purpura. Autoimmun Rev 2008, 7:179-184.
83. Erdoǧan O., Oner A., Aydin A., Işimer A., Demircin G., Bülbül M. Effect of vitamin E treatment on the oxidative damage occurring in Henoch-Schönlein purpura. Acta Paediatr 2003, 92:546-550.
84. Trapani S., Mariotti P., Resti M., Nappini L., de Martino M., Falcini F. Severe hemorrhagic bullous lesions in Henoch Schönlein purpura: three pediatric cases and review of the literature. Rheumatol Int 2010, 30:1355-1359.
85. Marzano A.V., Vezzoli P., Crosti C. Drug-induced lupus: an update on its dermatologic aspects. Lupus 2009, 18:935-940.
86. Marzano A.V., Lazzari R., Polloni I., Crosti C., Fabbri P., Cugno M. Drug-induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart. Br J Dermatol 2011, 165:335-341.
87. Levin J., Werth V.P. Skin disorders with arthritis. Best Pract Res Clin Rheumatol 2006, 20:809-826.
88. Marzano A.V., Trevisan V., Lazzari R., Crosti C. Pyoderma gangrenosum: study of 21 patients and proposal of a 'clinicotherapeutic' classification. J Dermatolog Treat 2011, 22:254-260.
89. Marzano A.V., Cugno M., Trevisan V., Fanoni D., Venegoni L., Berti E., et al. Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases. Clin Exp Immunol 2010, 162:100-107.
90. Jorizzo J.L. Clinical dermatol 1991, vol. 1. Lippincott, Philadelphia, section5-6. D.J. Demis (Ed.).
91. Lever W.F., Shaumberg-Lever G. Histopathology of the skin 1990, 185-206. Lippincott, Philadelphia. 7th ed.
92. Minkowitz G., Smoller B.R., McNutt N.S. Benign cutaneous polyarteritis nodosa. Relationship to systemic polyarteritis nodosa and to hepatitis B infection. Arch Dermatol 1991, 127:1520-1523.
93. Kumar L., Thapa B.R., Sarkar B., Walia B.N. Benign cutaneous polyarteritis nodosa in children below 10years of age-a clinical experience. Ann Rheum Dis 1995, 54:134-136.
94. Siberry G.K., Cohen B.A., Johnson B. Cutaneous polyarteritis nodosa. Reports of two cases in children and review of the literature. Arch Dermatol 1994, 130:884-889.
95. Jorizzo J.L., White W.L., Wise C.M., Zanolli M.D., Sherertz E.F. Low-dose weekly methotrexate for unusual neutrophilic vascular reactions: cutaneous polyarteritis nodosa and Behçet's disease. J Am Acad Dermatol 1991, 24:973-978.
96. Kawakami T., Soma Y. Use of warfarin therapy at a target international normalized ratio of 3.0 for cutaneous polyarteritis nodosa. J Am Acad Dermatol 2010, 63:602-606.
97. Vega Gutierrez J., Rodriguez Prieto M.A., Garcia Ruiz J.M. Successful treatment of childhood cutaneous polyarteritis nodosa with infliximab. J Eur Acad Dermatol Venereol 2007, 21:570-571.
98. Wegener F. über generalisierte, septische efäberkrankungen. Verh Dtsch Pathol Ges 1936, 29:202-210.
99. Moosig F., Lamprecht P., Gross W.L. Wegener's granulomatosis: the current view. Clin Rev Allergy Immunol 2008, 35:19-21.
100. Hoffman G.S., Kerr G.S., Leavitt R.Y., Hallahan C.W., Lebovics R.S., Travis W.D., et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992, 116:488-498.
101. Patten S.F., Tomecki K.J. Wegener's granulomatosis: cutaneous and oral mucosal disease. J Am Acad Dermatol 1993, 28:710-718.
102. Holle J.U., Gross W.L., Holl-Ulrich K., Ambrosch P., Noelle B., Both M., et al. Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage?. Ann Rheum Dis 2010, 69:1934-1939.
103. Marzano A.V., Balice Y., Papini M., Testa R., Berti E., Crosti C. Localized Wegener's granulomatosis. J Eur Acad Dermatol Venereol 2011, 25:1466-1470.
104. Ruokonen H., Helve T., Arola J., Hietanen J., Lindqvist C., Hagstrom J. "Strawberry like" gingivitis being the first sign of Wegener's granulomatosis. Eur J Intern Med 2009, 20:651-653.
105. Marzano A.V., Fanoni D., Berti E. Oral and cutaneous findings are valuable diagnostic aids in Wegener's granulomatosis. Eur J Intern Med 2010, 21:49.
106. Stewart C., Cohen D., Bhattacharyya I., Scheitler L., Riley S., Calamia K., et al. Oral manifestations of Wegener's granulomatosis: a report of three cases and a literature review. J Am Dent Assoc 2007, 138:338-348.
107. Nölle B., Specks U., Lüdemann J., Rohrbach M.S., DeRemee R.A., Gross W.L. Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis. Ann Intern Med 1989, 111:28-40.
108. Noth I., Strek M.E., Leff A.R. Churg-Strauss syndrome. Lancet 2003, 361:587-594.
109. Phillip R., Luqmani R. Mortality in systemic vasculitis: a systematic review. Clin Exp Rheumatol 2008, 26:S94-S104.
110. Garcia G., Achouh L., Cobarzan D., Fichet D., Humbert M. Severe thromboembolic disease in Churg-Strauss syndrome. Allergy 2005, 60:409-410.
111. Allenbach Y., Seror R., Pagnoux C., Teixeira L., Guilpain P., Guillevin L., et al. High frequency of nebous thromboembolic events in Churg-Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients. Ann Rheum Dis 2009, 68:564-567.
112. Ogbogu P.U., Rosing D.R., Horne M.K. Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am 2007, 27:457-475.
113. Marzano A.V., Tedeschi A., Rossio R., Fanoni D., Cugno M. Prothrombotic state in Churg-Strauss syndrome: a case report. J Investig Allergol Clin Immunol 2010, 20:616-619.
114. Marzano A.V., Tedeschi A., Fanoni F., Bonanni E., Venegoni L., Berti E., et al. Activation of blood coagulation in bullous pemphigoid: role of eosinophils, and local and systemic implications. Br J Dermatol 2009, 160:266-272.
115. Marzano A.V., Tedeschi A.R., Spinelli D., Fanoni D., Crosti C., Cugno M. Coagulation activation in autoimmune bullous diseases. Clin Exp Immunol 2009, 158:31-36.
116. Lhote F., Cohen P., Guillevin L. Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome. Lupus 1998, 7:238-258.